
Acta Crystallographica, Section C: Crystal Structure Communications p. 2030 - 2032 (1999)
Update date:2022-08-04
Topics:
Neels, Antonia
Stoeckli-Evans, Helen
Plasseraud, Laurent
Garcia Fidalgo, Eva
Suess-Fink, Georg
The homologous title molecules, [Ru2Br4(C10H14) 2]·-C6H6, (1), and [Ru2I4(C10H14) 2]·C7H8, (2), consist of arene-ruthenium moieties [Ru-to-ring distances of 1.655 (2) A in (1) and 1.673 (3) A in (2)] with a terminal halogen ligand [Ru - Br 2.548 (1) A in (1) and Ru - I 2.726 (1) A in (2)], held together by two symmetrical halogen bridges [Ru - Br 2.575 (1) A in (1) and Ru - I 2.736 (1) A in (2)]. The arene rings are planar and parallel to each other, and the terminal halogen ligands are coordinated to ruthenium trans with respect to each other. Both molecules possess Ci symmetry.
Anqing World Chemical Co., Ltd.
Contact:+86-556-5800026
Address:Daguan Economic Development Zone of circular economy industrial park Anqing City Anhui province
Contact:0086-29-88315623
Address:S711, Innovation Bldg No.25 Gaoxin 1st Rd, Xian P.R of China 710075
Changzhou Sunlight Pharmaceutical Co., Ltd.
Contact:+86-519-83131668;83139028;83138042;83137041
Address:JiuliStreet, Benniu Town Changzhou City, Jiangsu Province
Changzhou Ansciep Chemical Co.,Ltd.
Contact:+86 519 8630 5871
Address:A-710 Boan International, 8 East Guangdian Road,Wujin,Changzhou
Contact:+86-519-86623222
Address:29F/D, 99 Yanling West Road, Changzhou, Jiangsu, China
Doi:10.1039/c29710001506
(1971)Doi:10.1055/s-1999-3174
(1999)Doi:10.1021/ic990631y
(2000)Doi:10.1016/S0277-5387(99)00300-9
(1999)Doi:10.1248/cpb.52.1105
(2004)Doi:10.1002/(SICI)1522-2675(19991215)82:12<2260::AID-HLCA2260>3.0.CO;2-Z
(1999)